Cerevel Therapeutics Holdings Inc

NASDAQ:CERE   3:59:43 PM EDT
13.95
+0.34 (+2.50%)
Other Pre-Announcement

Cerevel Therapeutics Announces Third Quarter 2020 Financial Results And Key Business Highlights

Published: 11/16/2020 12:40 GMT
(CERE) - Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights.
Cerevel Therapeutics Holdings Inc Qtrly Loss per Share $5.49.
Cerevel Therapeutics Holdings Inc - Cash and Cash Equivalents Were $13 Million As of September 30 2020.
Cerevel Therapeutics Holdings Inc - Expects Its Cash and Cash Equivalents Will Be Sufficient to Fund Its Current Operating Plan Into 2023.